Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · fourth_quarter · Q4
Recommendations on the future role of ESRD (end stage renal disease) Networks
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · third_quarter · Q3
Source: Senate LDA
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Kidney Care Quality and Education Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Charlie W. Norwood Living Organ Donation Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Living Kidney Organ Donation Clarification Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
Kidney Care Quality and Education Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · second_quarter · Q2
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · third_quarter · Q3
Comments to proposed update to Physician Fee Schedule as it relates to payment to physicians for organ retrieval.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · second_quarter · Q2
Payment for treatment of health outcomes that result from dialysis care, under Proposed Rule for Hospital Inpatient Prospective Payment System.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · first_quarter · Q1
End Stage Renal Disease Clincial Performance Measures Program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · year_end · YY
Add Potassium as a required disclosure on nutrition labels.
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · mid_year · MM
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
* Inclusion of chronic kidney disease in Healthy People 2020 guideline. Medicare coverage of erythropoiesis stimulating agents (ESA's) for individuals with chronic kidney disease or chronic kidney failure. FDA labeling issues related to ESA's. Inclusion of chronic kidney disease in Healthy People 2020 guideline.
* Annual appropriations for Food and Drug Administration Funding for organ donation programs under the Health Resources and Services Administration. Annual appropriations for Food and Drug Administration
FY 2008 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Add Potassium as a required disclosure on nutrition labels.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE